Evaluating the Health Benefits of Physical Activity Recommendations in the Dietary Guidelines
FL52
1 other identifier
interventional
37
0 countries
N/A
Brief Summary
The overall goal of this study is to determine the health benefits associated with the 2005 Dietary Guidelines physical activity prescription in healthy, peri-menopausal women. The 2005 Dietary Guidelines specifically state that to avoid unhealthy weight gain, adults should participate in 60 minutes of moderate to vigorous intensity physical activity on most days of the week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Oct 2006
Longer than P75 for not_applicable obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 11, 2012
CompletedFirst Posted
Study publicly available on registry
September 19, 2012
CompletedSeptember 19, 2012
September 1, 2012
2.9 years
September 11, 2012
September 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in compliance with exercise
The Actiheart (MiniMitter, Bend OR) physical activity and heart rate logger is a motion sensor and heart rate monitor worn by subjects 24 hours per day(excluding bathing and swimming) for one week to determine the level of physical activity. Subjects will also use a pedometer to record the number of steps taken during their walking sessions. The Stanford 7 day Physical Activity recall questionnaire will also be used to assess physical activity.
0, 3 and 6 months
Secondary Outcomes (6)
Change in dietary intake
0, 6 months
Change in body composition
0, 3, and 6 months
Change in Chronic Disease Risk Assessment
0, 3 and 6 months
Change in measures of stress
0, 3 and 6 months
Change in aerobic fitness
0, 3, and 6 months
- +1 more secondary outcomes
Study Arms (2)
Physical Activity
EXPERIMENTALPhysical activity intervention will consist of brisk walking or other aerobic-type activities (6 days per week), resistance exercise (using free weights, resistance bands or weight stacks for weight lifting, 3 days per week), and 'active lifestyle' activities such as gardening, dancing, participation in sporting activities. The total time spent in these activities will add up to \~60 min/day for 6 days/week (\~360 minutes per week).
Control
OTHERThe control group will maintain their usual level of physical activity and participate in testing protocols, record keeping, and interviews.
Interventions
Physical activity intervention that will consist of brisk walking or other aerobic-type activities (6 days per week), resistance exercise (using free weights, resistance bands or weight stacks for weight lifting, 3 days per week), and 'active lifestyle' activities such as gardening, dancing, participation in sporting activities. The total time spent in these activities will add up to \~60 min/day for 6 days/week (\~360 minutes per week).
The control group will maintain their usual level of physical activity and participate in testing protocols, record keeping, and interviews.
Eligibility Criteria
You may qualify if:
- Body Mass Index: 18.5 to 29.9 kg/m2
- Peri-menopause, as determined by self-report of menstrual history and symptoms for previous 12 months
- Sedentary lifestyle
You may not qualify if:
- Individuals who are already physically active
- Pregnant or nursing within the last 6 months
- Plan to become pregnant during the study
- Musculoskeletal disease or disorder which is expected to limit participation in physical activity
- Orthopedic injuries
- Inflammatory arthritis or autoimmune disorders
- Neuromuscular disorders including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease
- Menopause confirmed
- Use of tobacco products
- Family history of premature cardiovascular disease as defined by the ACSM guidelines
- Cardiovascular including a history of cardiac arrest; coronary heart disease, complex ventricular arrhythmia or atrial arrhythmia at rest or with exercise, congestive heart failure, cardiomyopathy, hemodynamically significant valvular heart disease, left bundle block, cardiac pacemaker; implanted cardiac defibrillator; history of aortic aneurysm of at least 7 cm in diameter or aortic aneurysm repair; resting heart rate \< 45 beats per minute or \> 100 beats per minute
- Chronic lung disease resulting in dyspnea at rest or with minimal exertion, lung disease resulting in hypoxia or hypercapnia at rest or with exercise, pulmonary embolus within 6 months, active tuberculosis
- Presence of risk factors for cardiovascular or metabolic disease:
- Hypertension (SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg); hypertension treated by beta adrenergic blockers regardless of blood pressure
- Elevated fasting LDL cholesterol (≥160 mg/dL)
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy L Keim, PhD
USDA, ARS, Western Human Nutrition Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2012
First Posted
September 19, 2012
Study Start
October 1, 2006
Primary Completion
September 1, 2009
Study Completion
September 1, 2011
Last Updated
September 19, 2012
Record last verified: 2012-09